Clinical Study of Preoperative Prehabilitation Synchronized Neoadjuvant Chemotherapy for Gastric Cancer Patients

Table 1

Comparison of general conditions of gastric cancer patients in two groups.

Item	Control	Prehabilitation	/t value	value
Gender
Male	48	45	0.306	0.580
Female	20	23
Age
<65	58	59	0.061	0.803
≥65	10	9
BMI
<24	55	52	0.394	0.530
≥24	13	16
Clinical stages
IIIa	47	44	0.299	0.585
IIIb	21	24
Comorbidities
Without	44	46	0.131	0.717
With	24	22
Extent of gastrectomy
Distal	28	35	1.802	0.179
Total	35	27
6MWD (meters)	454.5 ± 79.8	447.8 ± 83.8	0.473	0.637
Serum albumin (g/L)	38.13 ± 3.92	37.58 ± 4.05	0.808	0.420
Serum prealbumin (mg/L)	286.2 ± 67.0	283.3 ± 61.5	0.268	0.789